Abeona Therapeutics Announces Resignation of Director Michael Amoroso

On June 11, 2026, Abeona Therapeutics Inc. reported the immediate resignation of Michael Amoroso from its Board of Directors. In addition to his role on the Board, Mr. Amoroso also resigned from his position on the Nominating and Corporate Governance Committee. According to the filing, the departure was not due to any disagreements with the company’s operations, policies, or practices, but was instead for personal reasons. The report was signed by Joseph Vazzano, the Chief Financial Officer of Abeona Therapeutics. No replacement for the board seat or committee position was named in this specific filing. This change follows the company's standard corporate governance procedures for reporting departures of key leadership personnel to the Securities and Exchange Commission.